tetano
Editor, Senior Moderator
J Gen Virol. 2018 Jun 26. doi: 10.1099/jgv.0.001101. [Epub ahead of print]
[h=1]Characterization of neutralizing epitopes in antigenic site B of recently circulating influenza A(H3N2) viruses.[/h] Beer K[SUP]1[/SUP], Dai M[SUP]1[/SUP], Howell S[SUP]2[/SUP], Rijal P[SUP]3[/SUP], Townsend AR[SUP]3[/SUP], Lin Y[SUP]1[/SUP], Wharton SA[SUP]1[/SUP], Daniels RS[SUP]1[/SUP], McCauley JW[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza A(H3N2) viruses are associated with outbreaks worldwide and can cause disease with severe complications. The impact can be reduced by vaccination, which induces neutralizing antibodies that mainly target the haemagglutinin glycoprotein (HA). In this study we generated neutralizing mouse monoclonal antibodies (mAbs) against A/Victoria/361/2011 and identified their epitopes by generating and sequencing escape viruses. The epitopes are located in antigenic site B, which is near the receptor-binding site and is immunodominant in humans. Amino acid (aa) substitutions at positions 156, 158, 159, 189, 190 and 193 in antigenic site B led to reduced ability of mAbs to block receptor-binding. The majority of A(H3N2) viruses that have been circulating since 2014 are antigenically distinct from previous A(H3N2) viruses. The neutralization-sensitive epitopes in antigenic site B of currently circulating viruses were examined with these mAbs. We found that clade 3C.2a viruses, possessing an additional potential glycosylation site at HA1 position N158, were poorly recognized by some of the mAbs, but other residues, notably at position 159, also affected antibody binding. Through a mass spectrometric (MS) analysis of HA, the glycosylated sites of HA1 were established and we determined that residue 158 of HA1 was glycosylated and so modified a neutralization-sensitive epitope. Understanding and monitoring individual epitopes is likely to improve vaccine strain selection.
PMID: 29944110 DOI: 10.1099/jgv.0.001101
[h=1]Characterization of neutralizing epitopes in antigenic site B of recently circulating influenza A(H3N2) viruses.[/h] Beer K[SUP]1[/SUP], Dai M[SUP]1[/SUP], Howell S[SUP]2[/SUP], Rijal P[SUP]3[/SUP], Townsend AR[SUP]3[/SUP], Lin Y[SUP]1[/SUP], Wharton SA[SUP]1[/SUP], Daniels RS[SUP]1[/SUP], McCauley JW[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza A(H3N2) viruses are associated with outbreaks worldwide and can cause disease with severe complications. The impact can be reduced by vaccination, which induces neutralizing antibodies that mainly target the haemagglutinin glycoprotein (HA). In this study we generated neutralizing mouse monoclonal antibodies (mAbs) against A/Victoria/361/2011 and identified their epitopes by generating and sequencing escape viruses. The epitopes are located in antigenic site B, which is near the receptor-binding site and is immunodominant in humans. Amino acid (aa) substitutions at positions 156, 158, 159, 189, 190 and 193 in antigenic site B led to reduced ability of mAbs to block receptor-binding. The majority of A(H3N2) viruses that have been circulating since 2014 are antigenically distinct from previous A(H3N2) viruses. The neutralization-sensitive epitopes in antigenic site B of currently circulating viruses were examined with these mAbs. We found that clade 3C.2a viruses, possessing an additional potential glycosylation site at HA1 position N158, were poorly recognized by some of the mAbs, but other residues, notably at position 159, also affected antibody binding. Through a mass spectrometric (MS) analysis of HA, the glycosylated sites of HA1 were established and we determined that residue 158 of HA1 was glycosylated and so modified a neutralization-sensitive epitope. Understanding and monitoring individual epitopes is likely to improve vaccine strain selection.
PMID: 29944110 DOI: 10.1099/jgv.0.001101